In HCT116 colorectal cancer cells, PAT4 regulates a form of mTORC1 that appears to be resistant to the drug rapamycin and seems to more strongly affect 4E-BP1 phosphorylation than S6K, in contrast to rapamycin-sensitive mTORC1. This evidence concerns the gene SLC36A4 and colorectal cancer.